Novartis Awaits Landmark Drug Patenting Decision
Big Pharma companies eagerly await the ruling of a landmark decision by The Supreme Court in India regarding drug patenting rules
Sectors - Pharmaceuticals
Bayer Loses Patent Fight Over Cancer Drug
Pharmaceutical giant Bayer has lost its legal fight to overturn the Indian government's decision to allow Natco Pharma to produce its cancer drug Nexavar under compulsory licence
RB & BMS Collaborate To Expand Into Latin America
Reckitt Benckiser and Bristol-Myers Squibb have announced a joint partnership to promote over-the-counter drugs in the emerging Latin American markets
Africa's Big Pharma Market To Be Worth $45bn By 2020
Big pharma companies are recognising great opportunity in the African continent
Perrigo Buys Rosemont Pharma For $283m
Perrigo Company today announced that it has signed a definitive merger agreement and has completed the acquisition of UK-based Rosemont Pharmaceuticals Ltd for approximately $283 million in cash
Sun Ends Efforts To Buyout Taro Pharma
Taro Pharmaceutical Industries and Sun Pharma have put the brakes on a buyout deal after an agreement could not be reached over price. Taro continues to see positive earnings and as such the price per share agreed in August was no longer accepted by the Board
GSK Announces European Restructuring Plans
GlaxoSmithKline has announced plans to cut costs in its struggling European drugs division and has promised investors a return in growth this year, after failing to deliver projected sales and margin recovery in 2012
Perrigo Acquires Pet Care Company Velcera For $160m
Perrigo acquires Velcera for $160 million to expand its animal healthcare division
Top Five Consumer Healthcare Companies
Life doesn't stop when you're not feeling well. From headaches to skin care, these Consumer Healthcare Companies have got you covered head to toe.
How can independent pharmacies create a sustainable future?
Should pharmacies be looking for a 'fee for service, not free for service' business model? And how long can independent community pharmacies continue to compete against the multiples?
Recession forcing strategic changes in pharma industry
Pharmaceutical manufacturers are having to change the way they do business in order to survive the current financial restraints
Rheumatoid arthritis patients given new treatment hope
Almost four times as many RA patients unable to take methotrexate achieve disease remission with RoActemra® compared to humira
Aspirin and ibuprofen can help prevent skin cancer
New research has suggested that common painkillers significantly reduce a person's risk of developing the disease
Gene discovery could lead to contraceptive pill for men
Researchers in the UK have identified a gene which is vital in the production of healthy sperm
A third of malaria drugs are fake, research finds
A study carried out by the National Institute of Health in America found that counterfeit malaria medications were particularly prevalent in Africa and South East Asia
Cheap arthritis drug is a promising dysentery treatment
Auranofin, which is sold under the trade name of ridaura, is reportedly 10 times more effective than the existing treatment for amoebic infections
Coil beats morning after pill after unprotected sex
An expert is claiming intrauterine devices such as the coil are much more effective methods of emergency contraception than the commonly used morning after pill
Abbott Laboratories fined $1.6bn for Depakote marketing
The pharmaceutical company marketed its anti-seizure medication as being suitable for things it had not been authorised for
Aspirin is as effective as warfarin for heart patients
That's according to the results of an international study of more than 2,000 heart failure patients
Access to over the counter contraceptives must increase
Health experts are arguing that girls as young as 13 should be able to get the Pill from pharmacies without a prescription
AstraZeneca CEO David Brennan to retire in June
The company's Chairman, Louis Schweitzer, has also announced his retirement three months early than expected
EMA approves Signifor as Cushing's disease treatment
The drug, which is manufactured by Novartis, is the first medical therapy for the rare hormonal disorder to be approved in Europe
AstraZeneca buys Ardea Biosciences for $1.26 billion
The pharmaceutical giant is hoping to boost its product line with Ardea's experimental drug treatments for gout and cancer
EMA supports use of Novartis' Gilenya MS drug treatment
Despite endorsing the continued use of the drug, the European Medicines Agency has said it needs to come with stronger warnings
Morning after pill to be delivered to women by courier
The new service, which will deliver the emergency contraception directly to women at their home or office, launches in the UK next week
Pharma giants lose out in urological disorders market
The expiration of a number of patents on key drugs will prove to be challenging for major pharmaceutical companies
New nasal spray 'vaccine' could prevent heart attacks
The revolutionary new drug is reportedly able to significantly reduce the amount of fat build up in the arteries
New £1-a-day drug slows the effect of arthritis
A study has suggested the breakthrough treatment could reduce the need for hip and knee replacements
Giving your pharma launch the creative edge
Cheryl Clarke, the founder and director of event management company evential, explains what's needed to make new product launches a success in the healthcare and pharmaceutical industries
Comb-free head lice treatment gets FDA approval
The newly approved Sklice lotion just takes one, 10 minute application for it to effectively kill head lice
University installs morning after pill vending machine
The US Food and Drug Administration is investigating claims that a college in America has installed a vending machine selling the morning after pill
Cholesterol-lowering statins can help to treat cancer
Scientists have found that a daily dose of statins can help to prevent cancerous tumours from growing and spreading around the body
Vaccine for meningitis B will be available by Spring
It is hoped the new vaccine, which protects children and teenagers against meningitis B will be available for patient use in the Spring
Popular cosmetic chemical found in breast cancer tissue
Parabens are widely used in everyday toiletries such as deodorants and face creams and are also present in food stuffs
New cream can cure cases of skin cancer without surgery
Patient trials of the radioactive paint have had a promising success rate of 95 percent
GSK to sell US consumer brands to Prestige for $660m
The acquisition of 17 North American brands, which include Gavison, Tagment and Beano, is thought to be the largest ever for Prestige Brands Holdings
NICE recommends anti-clotting drug Eliquis to patients
Although the drug lost out to Sanofi's Levenox in recent clinical trials which tested its effectiveness, its use has been recommended for its affordability
New cervical cancer jab protects against genital warts
The Department of Health in the UK will be changing the vaccine it uses in its HPV vaccination programme in September 2012
AstraZeneca thyroid cancer drug gets EU approval
The use of Caprelsa as a treatment for advanced thyroid cancer has been recommended by drug regulators in Europe
Electronic Prescriptions - Flying the flag for the NPfIT
The decision by the UK government to scrap the NHS' National Programme for IT continues to attract negative publicity, but one of its services with the potential to revolutionise healthcare is often forgotten about - the Electronic Prescription Service
Gonorrhoea 'untreatable' after becoming drug resistant
Health experts are warning the sexually transmitted infection is becoming increasingly difficult to treat and could soon be incurable
Banned obesity drug is approved for use in Brazil
Sibutramine has been banned in both the US and Europe, but its use has been given the go ahead by Brazilian authorities
Plunging off the patent cliff
With patents about to expire on the blockbuster drugs of the nineties, Healthcare Global explores the effect the 'patent cliff' will have on the pharmaceutical industry
London opens first ever 'Club Drug Clinic'
The new NHS clinic is designed to offer support to people addicted to popular clubbing drugs, such as mephedrone and ketamine
Orlistat under review after links to liver problems
Recent cases suggest there may be a link between the weight loss drug and liver damage
Greek hospitals have drug supply stopped by Roche
A number of state owned hospitals in Greece have seen their pharmaceutical supply halted after failing to pay bills
Sanofi wins Lipitor licence from Pfizer
A generic version of the world's best selling drug could be available before Pfizer loses its exclusive patent rights next year
Scenesse drug implant tans skin without cancer risk
Despite being designed to treat skin conditions such as EPP and vitiligo, the implant can give skin a tanned effect
Painkiller addiction rise leads to increase in deaths
The number of prescriptions for powerful painkillers has increased six fold in the last 20 years
Pfizer wins legal case to keep Viagra patent
TEVA has been banned from making a generic version of Pfizer's Viagra drug until 2019
